The current NRXP market cap is 27.69M. The company's latest EPS is USD -0.4737 and P/E is -0.70.
Quarter End | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Revenue | 0 | 0 | 0 | 0 | 0 |
Operating Income | -9.6M | -9.14M | -9.89M | -9.44M | -8.19M |
Net Income | -6.98M | -9.08M | -10.24M | -11.04M | -8.72M |
Year End December 30 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Revenue | 0 | 0 | 10.16M | 771k | 0 |
Operating Income | -1.01M | -713k | -51.39M | -115.8M | -44.34M |
Net Income | 66k | 408k | -51M | -348.89M | -39.75M |
Quarter End | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Assets | 32.43M | 24.82M | 25.82M | 21.78M | 19.81M |
Total Liabilities | 7.08M | 8.04M | 18.41M | 22.06M | 22.62M |
Total Equity | 25.35M | 16.78M | 7.41M | -284k | -2.81M |
Year End December 30 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Assets | 70.8M | 32.08M | 2.94M | 32.73M | 25.82M |
Total Liabilities | 1.26M | 2.58M | 46.72M | 11.92M | 18.41M |
Total Equity | 5M | 5M | -43.78M | 20.81M | 7.41M |
Quarter End | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Operating | -25.17M | -31.44M | -39.76M | -6.09M | -13.9M |
Investing | -6k | -11k | -10k | -4k | -2k |
Financing | 23.16M | 22.09M | 32.21M | 2.55M | 8.82M |
Year End December 30 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Operating | -473k | -793k | -2.27M | -37.7M | -39.76M |
Investing | -648k | 40.25M | -1,000 | -7k | -10k |
Financing | 683k | -39.47M | 3.25M | 63.46M | 32.21M |
Market Cap | 27.69M |
Price to Earnings Ratio | -0.70 |
Price to Sales Ratio | 0 |
Price to Cash Ratio | 1.38 |
Price to Book Ratio | 3.74 |
Dividend Yield | - |
Shares Outstanding | 83.92M |
Average Volume (1 week) | 314.18k |
Average Volume (1 Month) | 298.33k |
52 Week Change | -76.6% |
52 Week High | 1.45 |
52 Week Low | 0.221 |
Spread (Intraday) | 0 (0.93%) |
Company Name | NRX Pharmaceuticals Inc |
Address |
1201 orange st wilmington, delaware 19801 |
Website | https://www.nrxpharma.com |
Industry | blank checks (6770) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.